References

  1. Cronjé HS. Screening for cervical cancer in the developing world countries. Best Pract Res Clin Obstet Gynaecol. 2005; 19 (4):517-29. PubMed | Google Scholar

  2. Roblyer D, Richards-Kortum R, Park SY, Adewole I, Follen M. Objective screening for cervical cancer in developing nations: Lessons from Nigeria. GynecolOncol .2007; 107(1 Suppl 1):S94-7. PubMed | Google Scholar

  3. Anorlu RI. Cervical cancer: The sub-Saharan African perspective. Reprod Health Matters. 2008; 16 (32):41-9. PubMed | Google Scholar

  4. Meye JF, Mabika B, Belembaogo E, Engongah-Beka T, Minko-MiEtoua D. Position of cervix cancer detection in Gabon over a period of 19 years. Ann Pathol. 2001; 21 (3):233-6. PubMed | Google Scholar

  5. Nze-Nguema F, Sankaranarayanan R, Barthelemy M, Nguizi-Ogoula S, Whelan S, Minko-Mi-Etoua D. Cancer in Gabon, 1984-1993: a pathology registry based relative frequency study. Bull Cancer. 1996; 83 (9):693-6. PubMed | Google Scholar

  6. zur Hausen H. Papillomavirus infections a major cause of human cancers. BiochimBiophysActa. 1996; 1288 (2):F55-F78. PubMed | Google Scholar

  7. Bosch FX, Lorincz A, Munoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer. J ClinPathol. 2002; 55 (4):244-265. PubMed | Google Scholar

  8. Dochez C, Bogers JJ, Verhelst R, Rees H. HPV vaccines to prevent cervical cancer and genital warts: an update.Vaccine. 2014; 32 (14):1595-601. PubMed | Google Scholar

  9. Castle PE, Giuliano AR.Chapter 4: Genital tract infections, cervical inflammation, and antioxidant nutrients assessing their roles as human papillomavirus cofactors.J Natl Cancer InstMonogr. 2003; 31:29-34. PubMed | Google Scholar

  10. Bayo S, Bosch FX, de Sanjosé S, Muñoz N, Combita AL, Coursaget P et al. Risk factors of invasive cervical cancer in Mali. Int J Epidemiol. 2002; 31 (1):202-9. PubMed | Google Scholar

  11. WHO. La lutte contre le cancer du col de l'utérus : guide des pratiques essentielles. 2007; Genève :OMS. Google Scholar

  12. Goldie S, Gaffikin L, Goldhaber-Fiebert J,Gordillo-Tobar A, Levin C, Mahe C et al. Cost effectiveness of cervical screening in five developing countries. N Engl J Med .2005; 353 (20):2158-2168. PubMed | Google Scholar

  13. Katz IT, Wright AA. Preventing cervical cancer in the developing world. N Engl J Med. 2006; 354 (11):1110. PubMed | Google Scholar

  14. Gage JC, Ferreccio C, Gonzales M, Arroyo R, Huivin M, Robles SC. Follow-up care of women with an abnormal cytology in a low-resource setting. Cancer Detect Prev.2003; 27 (6):466-471. PubMed | Google Scholar

  15. Anorlu RI, Ola ER, Abudu OO. Low cost methods for secondary prevention of cervical cancer in developing countries. Niger Postgrad Med J. 2007; 14 (14):242-246. PubMed | Google Scholar

  16. Sankaranarayanan R, Basu P, Wesley RS,Mahe C, Keita N, Mbalawa CC et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. Int J Cancer. 2004; 110 (6):907-913. PubMed | Google Scholar

  17. University of Zimbabwe, JHPIEGO Cervical Cancer project. Visual inspection with acetic acid for cervical cancer screening: Test qualities in primary-care setting. Lancet. 1999; 353 (9156): 869-873. PubMed | Google Scholar

  18. Sellors JW, Sankaranarayanan R. Colposcopy and Treatment on Cervical Intraepithelial Neoplasia: A Beginners' Manual, 2003; Lyon, France: IARC Press. Google Scholar

  19. Sankaranarayanan R, Wesley R, Thara S,Dhakad N, Chandralekha B, Sebastian P et al. Test characteristics of visual inspection with 4% acetic acid (VIA) and Lugol's iodine (VILI) in cervical cancer screening in Kerala, India. Int J Cancer. 2003; 106 (3):404-408. PubMed | Google Scholar

  20. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA .2002;287 (16):2114-2119. PubMed | Google Scholar

  21. Adefuye A, Sales K. Regulation of inflammatory pathways in cancer and infectious disease of the cervix. Scientifica (Cairo). 2012; 2012:548150. PubMed | Google Scholar

  22. Bentsi C, Klufio CA, Perine PL, Bell TA, Cles LD, Koester CM, et al. Genital infections with Chlamydia trachomatis and Neisseria gonorrhoeae in Ghanaian women. Genitourin Med. 1985;61 (1):48-50. PubMed | Google Scholar

  23. Nwachokor FN, Forae GC. Morphological spectrum of non-neoplastic lesions of the uterine cervix in Warri, South-South, Nigeria. Niger J ClinPract. 2013;16 (4):429-432. PubMed | Google Scholar

  24. Marchand L, Van Dinter M, Mundt M, Dingel W, Klein G.Current cervical cancer screening practices of Dane County, Wisconsin primary care clinicians.WMJ. 2003;102 (3):35-40. PubMed | Google Scholar

  25. Parashari A, Singh V.Reasons for Variation in Sensitivity and Specificity of Visual Inspection with Acetic Acid (VIA) for the Detection of Pre-Cancer and Cancer Lesions of Uterine Cervix. Asian Pac J Cancer Prev. 2013; 14 (12): 7761-7762. PubMed | Google Scholar